DAXXIFY Trademark
Trademark Overview
On Thursday, February 23, 2023, a trademark application was filed for DAXXIFY with the United States Patent and Trademark Office. The USPTO has given the DAXXIFY trademark a serial number of 97809052. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, May 23, 2025. This trademark is owned by Revance Therapeutics, Inc.. The DAXXIFY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, muscle
spasms, and pain
General Information
| Serial Number | 97809052 |
| Word Mark | DAXXIFY |
| Filing Date | Thursday, February 23, 2023 |
| Status | 819 - SU - REGISTRATION REVIEW COMPLETE |
| Status Date | Friday, May 23, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 2, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, muscle
spasms, and pain |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 14, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, September 26, 2022 |
| First Use In Commerce Date | Saturday, September 30, 2023 |
Trademark Owner History
| Party Name | Revance Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Party Name | Revance Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
Trademark Events
| Event Date | Event Description |
| Monday, February 27, 2023 | NEW APPLICATION ENTERED |
| Tuesday, March 14, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 21, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, January 2, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, November 27, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 13, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 2, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 27, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 27, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 27, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, August 27, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, August 27, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, February 20, 2025 | USE AMENDMENT FILED |
| Thursday, February 20, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Monday, May 12, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, May 23, 2025 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Friday, May 23, 2025 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Friday, May 9, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
